Publications by authors named "Pascal Guibord"

Claim this Profile
E
Efficacy, Safety, and Pharmacodynamic Effects of the Bruton's Tyrosine Kinase Inhibitor Fenebrutinib (GDC-0853) in Systemic Lupus Erythematosus: Results of a Phase II, Randomized, Double-Blind, Placebo-Controlled Trial.
David Isenberg, Richard Furie, Nicholas S Jones, Pascal Guibord, Joshua Galanter

Arthritis Rheumatol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of new partial AUC parameters for evaluating the bioequivalence of prolonged-release formulations.
Michaël Boily, Catherine Dussault, Julie Massicotte, Pascal Guibord, Marc Lefebvre

Eur J Pharm Sci· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic dose proportionality between two strengths (12.5 mg and 25 mg) of doxylamine hydrogen succinate film-coated tablets in fasting state: a single-dose, randomized, two-period crossover study in healthy volunteers.
Sebastián Videla, Jesús Cebrecos, Mounia Lahjou, France Wagner, Pascal Guibord

Drugs R D· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Food effects on the pharmacokinetics of doxylamine hydrogen succinate 25 mg film-coated tablets: a single-dose, randomized, two-period crossover study in healthy volunteers.
Sebastián Videla, Mounia Lahjou, Pascal Guibord, Zhengguo Xu, Carles Tolrà

Drugs R D· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of naproxen using DBS: evaluation & pharmacokinetic comparison of human plasma versus human blood DBS.
Nikolay Youhnovski, Josée Michon, Sylvain Latour, Jean-Nicholas Mess, Annik Bergeron, Pascal Guibord

Bioanalysis· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis